Inventor · disambiguated record
Samuel Chackalamannil
Also filed as: CHACKALAMANNIL SAMUEL
77 granted patents·17 pending applications·1,682 citations·filing 1986–2014
99Inventor score
Files withSCHERING CORP57NEELAMKAVIL SANTHOSH FRANCIS6BOYLE CRAIG D5MERCK SHARP & DOHME5CHACKALAMANNIL SAMUEL3
Top patents by PatentIndex Score
94 records- 0198US6821978B2Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2001·Granted Nov 23, 2004·140 cites·34 claims
- 0298US5883096AMuscarinic antagonistsSCHERING CORP·Filed 1996·Granted Mar 16, 1999·164 cites·17 claims
- 0397US6326380B1Thrombin receptor antagonistsSCHERING CORP·Filed 2000·Granted Dec 4, 2001·103 cites·10 claims
- 0497US6063847AThrombin receptor antagonistsSCHERING CORP·Filed 1998·Granted May 16, 2000·180 cites·18 claims
- 0596US6645987B2Nor-seco himbacine derivatives useful as thrombin receptor antagonistsSCHERING CORP·Filed 2001·Granted Nov 11, 2003·97 cites·14 claims
- 0696US6037352AMuscarinic antagonistsSCHERING CORP·Filed 1998·Granted Mar 14, 2000·90 cites·11 claims
- 0796US5977138AEther muscarinic antagonistsSCHERING CORP·Filed 1997·Granted Nov 2, 1999·99 cites·19 claims
- 0895US5939419A2-benzyl-polycyclic guanine derivatives and process for preparing themSCHERING PLOUGH CORP·Filed 1994·Granted Aug 17, 1999·83 cites·9 claims
- 0994US6630475B2Adenosine A2a receptor antagonistsSCHERING CORP·Filed 2001·Granted Oct 7, 2003·53 cites·17 claims
- 1093US5889006AMuscarinic antagonistsSCHERING CORP·Filed 1996·Granted Mar 30, 1999·123 cites·18 claims
- 1192US7304078B2Thrombin receptor antagonistsSCHERING CORP·Filed 2003·Granted Dec 4, 2007·43 cites·67 claims
- 1292US7037920B2Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonistsSCHERING CORP·Filed 2002·Granted May 2, 2006·52 cites·15 claims
- 1392US6969719B2Polycyclic guanine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2002·Granted Nov 29, 2005·59 cites·26 claims
- 1491US7776889B2Spirocyclic thrombin receptor antagonistsSCHERING CORP·Filed 2006·Granted Aug 17, 2010·20 cites·8 claims
- 1590US8907095B2Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119XIA YAN·Filed 2008·Granted Dec 9, 2014·23 cites·14 claims
- 1690US6288068B1Muscarinic antagonistsSCHERING CORP·Filed 2000·Granted Sep 11, 2001·22 cites·5 claims
- 1788US6894065B2Thrombin receptor antagonistsSCHERING CORP·Filed 2003·Granted May 17, 2005·31 cites·16 claims
- 1887US6897217B22-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2004·Granted May 24, 2005·25 cites·21 claims
- 1986US7713999B2Thrombin receptor antagonistsSCHERING CORP·Filed 2007·Granted May 11, 2010·8 cites·46 claims
- 2085US8278334B2Cyclic amine BACE-1 inhibitors having a benzamide substituentCUMMING JARED N·Filed 2009·Granted Oct 2, 2012·7 cites·10 claims
- 2184US8987195B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 24, 2015·9 cites·27 claims
- 2284US7572802B27-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amineSCHERING CORP·Filed 2006·Granted Aug 11, 2009·7 cites·15 claims
- 2384US5608067A4-substituted pyrazoloquinoline derivativesFiled 1994·Granted Mar 4, 1997·25 cites·4 claims
- 2483US8815876B2Bicyclic heterocycle derivatives and methods of use thereofNEELAMKAVIL SANTHOSH FRANCIS·Filed 2009·Granted Aug 26, 2014·7 cites·16 claims
- 2582US8003803B2Fused ring thrombin receptor antagonistsSCHERING CORP·Filed 2007·Granted Aug 23, 2011·4 cites·4 claims
- 2682US6916811B2Adenosine A2a receptor antagonistsSCHERING CORP·Filed 2002·Granted Jul 12, 2005·17 cites·9 claims
- 2782US6043255AMuscarinic antagonistsSCHERING CORP·Filed 1999·Granted Mar 28, 2000·50 cites·16 claims
- 2881US9328138B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted May 3, 2016·8 cites·17 claims
- 2981US8022088B2Substituted bicyclic and tricyclic thrombin receptor antagonistsSCHERING CORP·Filed 2007·Granted Sep 20, 2011·5 cites·10 claims
- 3081US7713985B2Adenosine Aa2 receptor antagonistsSCHERING CORP·Filed 2007·Granted May 11, 2010·4 cites·13 claims
- 3181US7531544B2Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2007·Granted May 12, 2009·2 cites·3 claims
- 3280US7888369B2Oxazoloisoquinoline derivatives as thrombin receptor antagonistsSCHERING CORP·Filed 2006·Granted Feb 15, 2011·4 cites·8 claims
- 3380US7662816B2Cyclic amine BACE-1 inhibitors having a benzamide substituentSCHERING CORP·Filed 2004·Granted Feb 16, 2010·11 cites·25 claims
- 3480US7488752B2Thrombin receptor antagonistsSCHERING CORP·Filed 2005·Granted Feb 10, 2009·6 cites·25 claims
- 3580US7368449B22-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2005·Granted May 6, 2008·4 cites·16 claims
- 3679US7442712B2Constrained himbacine analogs as thrombin receptor antagonistsSCHERING CORP·Filed 2005·Granted Oct 28, 2008·6 cites·15 claims
- 3778US7465740B22-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2006·Granted Dec 16, 2008·3 cites·17 claims
- 3876US8318751B2Pyrimidinone derivatives and methods of use thereofBOYLE CRAIG D·Filed 2008·Granted Nov 27, 2012·3 cites·42 claims
- 3976US6890936B2Muscarinic antagonistsSCHERING CORP·Filed 2003·Granted May 10, 2005·9 cites·26 claims
- 4075US8389532B27-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amineBOYLE CRAIG D·Filed 2009·Granted Mar 5, 2013·2 cites·4 claims
- 4174US7709492B2Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2005·Granted May 4, 2010·2 cites·20 claims
- 4274US7488742B2Thrombin receptor antagonistsSCHERING CORP·Filed 2003·Granted Feb 10, 2009·5 cites·15 claims
- 4374US6897216B2Adenosine A2a receptor antagonistsSCHERING CORP·Filed 2003·Granted May 24, 2005·5 cites·6 claims
- 4474US6498168B2Muscarinic antagonistsSCHERING CORP·Filed 2001·Granted Dec 24, 2002·5 cites·5 claims
- 4572US9062007B2Cyclic amide BACE-1 inhibitors having a benzamide substituentPHARMACOPEIA DRUG DISCOVERY·Filed 2014·Granted Jun 23, 2015·1 cites·6 claims
- 4672USRE44205EAdenosine A2a receptor antagonistsNEUSTADT BERNARD R·Filed 2012·Granted May 7, 2013·2 cites·21 claims
- 4772US7741318B2Pyrazolo [1,5-A]pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2005·Granted Jun 22, 2010·2 cites·20 claims
- 4872US7268141B2Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2004·Granted Sep 11, 2007·4 cites·22 claims
- 4971US8822480B2Bicyclic heterocycle derivatives and use thereof as GPR119 modulatorsNEELAMKAVIL SANTHOSH FRANCIS·Filed 2009·Granted Sep 2, 2014·1 cites·19 claims
- 5071US5476847ADerivatives of phosphinic acid useful as endothelin converting enzyme inhibitorsSCHERING CORP·Filed 1994·Granted Dec 19, 1995·25 cites·29 claims
Showing the top 50 of 94 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →